Specialties

View All Specialties

Related Links:

Providers with this Specialty

Studies Currently Enrolling

StudyDetails
Diabetes studies 1) Patients on oral diabetic medications. This study looks at the effect of an investigational medication on patient's blood pressure and heart rate.
2) Patients who are on insulin, with or without oral diabetic medication. Investigational medication is a once-weekly injection given in addition to current diabetic medications.
3) Patients on Lantus - study to determine patient preference of using SoloSTAR pen versus conventional syringe for injections.
4) Patients over age 18, with hemoglobin A1C values of 7 to 10 while on Actos alone or Actos plus metformin.
Hepatitis C Patients over age 18 who have hepatitis C, genotype 1 and have not been previously treated with interferon. Compares study drug plus Copegus to study drug alone
Implantable Cardioverter Defibrillator (ICD) Patients who are candidates for an implantable device to treat life-threatening ventricular tachyarrthmias, or who have an existing device which requires replacement or revision. Must be over age 18.
Pediatric / adolescent studies (not yet open) Two studies of a vaccine for meningoccal group B disease. In one study (ages 10 to 13) patients will also receive Tdap (tetanus, diphtheria) and MCV4 boosters. In the other study (ages 11 to 17) patients will receive Gardasil (HPV vaccine) in addition to meningoccal group B study drug.
Rheumatoid Arthritis Study medication is an oral anti-TNF agent.
You may qualify if you have active disease (6 tender/painful joints and 6 swollen joints; are on a stable dose of methotrexate; and have had an inadequate response or failure to tolerate at least one TNF-inhibiting agent (Remicade, Enbrel, Humira, Orencia).

This service is offered at:

  • Sample Image - Created 11/15/2006

Additional Resources

Link to Making the Decision